Tag: phase III

February 6, 2019

Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia

Eyenovia (NASDAQ:EYEN) has announced that the US Food and Drug Administration has accepted its Investigational New Drug (IND) application to...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
September 28, 2018
May 8, 2018

Advantage Lithium Commences Preliminary Economic Assessment and Phase III Resource Conversion Program for the Cauchari Definitive Feasibility Study

Advantage Lithium Corp (TSXV:AAL; OTCQX:AVLIF) is pleased to announce that is has engaged WorleyParsons Chile S.A. (WP) to complete a...
April 25, 2018

U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

Pluristem Therapeutics (Nasdaq:PSTI) a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA)...
April 18, 2018

SilverCrest Delineates 10th High-Grade Vein at Las Chispas

SilverCrest Metals Inc. announced drill results from the Luigi vein on the Las Chispas property located in Sonora, Mexico.
April 9, 2018

Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that the independent Data Monitoring Committee (DMC) for the Company’s...